Skip to main contentSkip to navigation
Sirius Investors
Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
NASDAQHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for LIMN. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
14.49M
-91.62% over period
CAGR: -46.17%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
15.59M
-90.96% over period
CAGR: -45.15%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2026

EV/EBITDA

Distorted

-3.28x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

1.10M

EV is +7.6% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +7.8 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 0.42x

Share count change in dataset: -31.15%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202514.49M15.59M$0.6123.75M
Dec 31, 202436.03M40.35M$5.017.19M
Dec 31, 202340.14M55.76M$5.018.01M
Dec 31, 2022
Dec 31, 2021

Enterprise Value Analysis

Price Change (Dec 2024 to Dec 2025)

The stock price has decreased from Dec 2024 to Dec 2025.
-87.82%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.38

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-0.58

Market Cap Change (Dec 2024 to Dec 2025)

The company's market capitalization has decreased from Dec 2024 to Dec 2025.
-59.78%

Enterprise Value Change (Dec 2024 to Dec 2025)

The company's enterprise value has decreased from Dec 2024 to Dec 2025, suggesting a decline in the company's total economic value.
-61.35%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-46.17%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-45.15%